Lucid Group Inc
F:CH2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lucid Group Inc
F:CH2
|
US |
|
V
|
Valero Energy Corp
F:V1L
|
US |
|
H
|
Hess Corp
XMUN:AHC
|
US |
|
Oriental Land Co Ltd
F:OLL
|
JP |
|
Koninklijke Ahold Delhaize NV
MIL:1AD
|
NL |
|
Novartis AG
F:NOT
|
CH |
|
L
|
LyondellBasell Industries NV
LSE:0EDD
|
UK |
|
J
|
Japan Tobacco Inc
XMUN:JAT
|
JP |
|
A
|
Abeona Therapeutics Inc
F:PCJP
|
US |
|
H
|
Henry Schein Inc
F:HS2
|
US |
|
F
|
Fennec Pharmaceuticals Inc
NASDAQ:FENC
|
US |
|
E
|
Exelon Corp
BMV:EXC
|
US |
|
New China Life Insurance Co Ltd
F:NCL
|
CN |
|
3
|
3U Holding AG
DUS:UUU
|
DE |
|
H
|
Home Depot Inc
F:HDI
|
US |
|
Lynas Rare Earths Ltd
ASX:LYC
|
MY |
Wall St Price Targets
CH2 Price Targets Summary
Lucid Group Inc
According to Wall Street analysts, the average 1-year price target for
CH2 is 6.99 EUR with a low forecast of 3.87 EUR and a high forecast of 13.69 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CH2's stock price target?
Price Target
6.99
EUR
According to Wall Street analysts, the average 1-year price target for
CH2 is 6.99 EUR with a low forecast of 3.87 EUR and a high forecast of 13.69 EUR.
What is the Revenue forecast for Lucid Group Inc?
Projected CAGR
86%
Over the last 5 years, the compound annual growth rate for Revenue has been 221%. The projected CAGR for the next 3 years is 86%.